Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Peter Singleton who wrote (4544)	6/23/1998 11:44:00 PM
From: Bhag Karamchandani	Read Replies (1) of 6136

Peter: Thanks for the additional insight. Look forward to further input from you. The British Biotech coverage, posted by billkirn, does suggest a shift in their approach to tackling Cancer. It would be interesting to see Marimastat and AG3340 comparisons as their respective PIII results are announced. Your comments persuade me to see AGPH more favorably vis-a- vis their strategy for maximizing the approval of AG3340. Thanks again.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next